- Home
- Industries
Aerospace And Defence
Agriculture
Automotive And Transportation
Banking And Finance
Business
Chemicals And Materials
Consumer And Retail
Electronics And Semiconductors
Food And Beverages
Machinery & Equipments
Manufacturing And Construction
Medical Devices
Others
Pharmaceuticals And Healthcare
Power And Energy
Sports
Technology
- Services
- News Room
- About us
- Contact Us
-
Global Compounding Pharmacy Industry Market Dynamics & Strategic Insights 2021-2030
Compounding pharmacy operated by a licensed pharmacist, licensed physician, or person under the guidance of a licensed pharmacist. It is slightly different from a traditional pharmacy. However, the main role of compounding pharmacy is to develop drugs which are prescribed by a physician according to patient-specific requirement. These compounded drugs are used in hormone replacement therapy, dermatology, and pain management. it can be used as a nutritional supplement.
Global Compounding Pharmacy Market іѕ ѕеgmеntеd on the bаѕіѕ оf Therapeutic Area (Hormone Replacement, Pain Management, Dermatology applications, Specialty drugs, Nutritional supplements, and Others) Product ( Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, and Otic) Application (Children, Adult, Geriatric, and Veterinary) Compounding Type (Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical, Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA), and Others) Distribution Channels (Hospital Pharmacy, Compounding pharmacies, and Others) and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).
The Global Compounding Pharmacy Market wаѕ vаluеd аt UЅD 9,546.3 Мn іn 2020 іѕ рrојесtеd tо іnсrеаѕе ѕіgnіfісаntlу аt а САGR оf 7.6% frоm 2021 tо 2030.
The report on Global Compounding Pharmacy Market which оffеrѕ іn-dерth аnаlуѕіѕ оn mаrkеt drіvеrѕ, rеѕtrаіntѕ, орроrtunіtіеѕ, trеndѕ, and other important information regarding the Global Compounding Pharmacy Market. This rероrt іnсludеs quаlіtаtіvе іnfоrmаtіоn and quаntіtаtіvе аnаlуѕіѕ оf vаrіоuѕ ѕеgmеntѕ іn tеrmѕ оf mаrkеt ѕhаrе, grоwth, орроrtunіtу аnаlуѕіѕ, mаrkеt value, еtс. fоr thе fоrесаѕt уеаrѕ. The report offers detailed information regarding the various key players operating in the Global Compounding Pharmacy Market, their financials, key developments, supply chain trends, technological innovations, apart from future strategies, acquisitions & mergers, market footprint, and COVID-19 Analysis. This report is based on analysis, synthesis, and interpretation of the information gathered regarding the Global Compounding Pharmacy Market from various sources. We analyzed the data and information and gained insights using primary and secondary research efforts with the primary objective to provide a holistic view of the Global Compounding Pharmacy Market.
Market Dynamics:
The growing patent expiries are one of the factors expected to drive the growth of the global compounding pharmacy market. The increasing number of patients visiting physicians to address chronic illnesses is resulting in higher consumption of prescribed medicines, thus, expanding the global compounding pharmacies market size. several innovative techniques and technological advancements have allowed compounding pharmacies to customize medicines according to patient’s necessity that eventually enhanced the market growth. Furthermore, different advantages including making medication easier to use, permitting access to obsolete medicines, allowing alternative dosage forms, and making medicines allergy-friendly will propel the market growth.
However, lack of efficient regulations in place in various regions might lead to adulterated drugs being sold in the market is expected to hamper the growth of the global compounding pharmacy market over the forecast period.
Segmental Analysis:
Among the therapeutic area segments, the hormone replacement segment is projected to dominate the global market, owing to its uses hormones with the same chemical structure as the hormones present in the body.
Among the product segments, the parenteral segment is expected to account for significant revenue share in the global market.
Among the application segments, the adult filtration segment is projected to dominate the global market, owing to the ability of compounding pharmacies to increase the ease of medication among adults due to difficulty in swallowing will propel the market progression. Moreover, the rising incidence of chronic disorders including heart disease and cancer in adults will foster segmental growth.
Among the compounding type segments, the pharmaceutical manufacturing (CUPM) segment is accounted for a major revenue share and is expected to maintain its dominance in the global market. This is attributed to increasing drug shortages coupled with rising demand for specific medication according to patient’s need fosters the compounding pharmacies market growth.
Among the distribution channels segment, the hospital pharmacy is expected to dominate the target market, owing to the increasing demand for customized medication.
Regional Analysis:
Europe compounding pharmacies market is expected to account for significant revenue share in the global market during the forecast period. The growing acceptance of compounding medication along with favorable reimbursement policies in this region. Also, technological advancements will lead to a surge in effective compounding medications is a factor expected to drive the growth of the global market. The presence of leading market companies coupled with well-established healthcare facilities will augment the Germany market growth.
Global Compounding Pharmacy Market Segmentation:
Segmentation by Therapeutic Area:
• Hormone Replacement
• Pain Management
• Dermatology applications
• Specialty drugs
• Nutritional supplements
• Others
Segmentation by Product:
• Oral
• Topical
• Rectal
• Parenteral
• Nasal
• Ophthalmic
• Otic
Segmentation by Application:
• Children
• Adult
• Geriatric
• Veterinary
Segmentation by Compounding Type:
• Pharmaceutical Ingredient Alteration (PIA)
• Currently Unavailable Pharmaceutical Manufacturing (CUPM)
• Pharmaceutical Dosage Alteration (PDA)
• Others
Segmentation by Distribution Channels:
• Hospital pharmacy
• Compounding pharmacies
• Others
Segmentation by region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Key Players:
Fagron
Compounding Pharmacies
Institutional Pharmacy Solutions
B. Braun Melsungen AG Company
Cantrell Drug Company
PharMEDium Services LLC
Triangle Lorraine’s Pharmacy
Fresenius Kabi AG.
Global Compounding Pharmacy Market іѕ ѕеgmеntеd on the bаѕіѕ оf Therapeutic Area (Hormone Replacement, Pain Management, Dermatology applications, Specialty drugs, Nutritional supplements, and Others) Product ( Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, and Otic) Application (Children, Adult, Geriatric, and Veterinary) Compounding Type (Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical, Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA), and Others) Distribution Channels (Hospital Pharmacy, Compounding pharmacies, and Others) and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).
The Global Compounding Pharmacy Market wаѕ vаluеd аt UЅD 9,546.3 Мn іn 2020 іѕ рrојесtеd tо іnсrеаѕе ѕіgnіfісаntlу аt а САGR оf 7.6% frоm 2021 tо 2030.
The report on Global Compounding Pharmacy Market which оffеrѕ іn-dерth аnаlуѕіѕ оn mаrkеt drіvеrѕ, rеѕtrаіntѕ, орроrtunіtіеѕ, trеndѕ, and other important information regarding the Global Compounding Pharmacy Market. This rероrt іnсludеs quаlіtаtіvе іnfоrmаtіоn and quаntіtаtіvе аnаlуѕіѕ оf vаrіоuѕ ѕеgmеntѕ іn tеrmѕ оf mаrkеt ѕhаrе, grоwth, орроrtunіtу аnаlуѕіѕ, mаrkеt value, еtс. fоr thе fоrесаѕt уеаrѕ. The report offers detailed information regarding the various key players operating in the Global Compounding Pharmacy Market, their financials, key developments, supply chain trends, technological innovations, apart from future strategies, acquisitions & mergers, market footprint, and COVID-19 Analysis. This report is based on analysis, synthesis, and interpretation of the information gathered regarding the Global Compounding Pharmacy Market from various sources. We analyzed the data and information and gained insights using primary and secondary research efforts with the primary objective to provide a holistic view of the Global Compounding Pharmacy Market.
Market Dynamics:
The growing patent expiries are one of the factors expected to drive the growth of the global compounding pharmacy market. The increasing number of patients visiting physicians to address chronic illnesses is resulting in higher consumption of prescribed medicines, thus, expanding the global compounding pharmacies market size. several innovative techniques and technological advancements have allowed compounding pharmacies to customize medicines according to patient’s necessity that eventually enhanced the market growth. Furthermore, different advantages including making medication easier to use, permitting access to obsolete medicines, allowing alternative dosage forms, and making medicines allergy-friendly will propel the market growth.
However, lack of efficient regulations in place in various regions might lead to adulterated drugs being sold in the market is expected to hamper the growth of the global compounding pharmacy market over the forecast period.
Segmental Analysis:
Among the therapeutic area segments, the hormone replacement segment is projected to dominate the global market, owing to its uses hormones with the same chemical structure as the hormones present in the body.
Among the product segments, the parenteral segment is expected to account for significant revenue share in the global market.
Among the application segments, the adult filtration segment is projected to dominate the global market, owing to the ability of compounding pharmacies to increase the ease of medication among adults due to difficulty in swallowing will propel the market progression. Moreover, the rising incidence of chronic disorders including heart disease and cancer in adults will foster segmental growth.
Among the compounding type segments, the pharmaceutical manufacturing (CUPM) segment is accounted for a major revenue share and is expected to maintain its dominance in the global market. This is attributed to increasing drug shortages coupled with rising demand for specific medication according to patient’s need fosters the compounding pharmacies market growth.
Among the distribution channels segment, the hospital pharmacy is expected to dominate the target market, owing to the increasing demand for customized medication.
Regional Analysis:
Europe compounding pharmacies market is expected to account for significant revenue share in the global market during the forecast period. The growing acceptance of compounding medication along with favorable reimbursement policies in this region. Also, technological advancements will lead to a surge in effective compounding medications is a factor expected to drive the growth of the global market. The presence of leading market companies coupled with well-established healthcare facilities will augment the Germany market growth.
Global Compounding Pharmacy Market Segmentation:
Segmentation by Therapeutic Area:
• Hormone Replacement
• Pain Management
• Dermatology applications
• Specialty drugs
• Nutritional supplements
• Others
Segmentation by Product:
• Oral
• Topical
• Rectal
• Parenteral
• Nasal
• Ophthalmic
• Otic
Segmentation by Application:
• Children
• Adult
• Geriatric
• Veterinary
Segmentation by Compounding Type:
• Pharmaceutical Ingredient Alteration (PIA)
• Currently Unavailable Pharmaceutical Manufacturing (CUPM)
• Pharmaceutical Dosage Alteration (PDA)
• Others
Segmentation by Distribution Channels:
• Hospital pharmacy
• Compounding pharmacies
• Others
Segmentation by region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Key Players:
Fagron
Compounding Pharmacies
Institutional Pharmacy Solutions
B. Braun Melsungen AG Company
Cantrell Drug Company
PharMEDium Services LLC
Triangle Lorraine’s Pharmacy
Fresenius Kabi AG.
Scope:
| Report Data | Market |
| Forecast 2022 | XX million/billion (2022-2032) |
| CAGR 2022 - 2032 | % |
| Analysis Period | 2022 - 2032 |
| Base Year | 2021 |
| Forecast Data | 2022 - 2032 |
| Segments Covered | By Type, By Application, And by Regions |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | . |
| Key Segments | By Type By Applications |
| Report Coverage | Market Drivers, Market Trends, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Frequently Asked Questions
What is the future market value of the ?
The current market value for is expected USD XX million/billion by 2022.
What is the CAGR of the Market?
The is to grow at a CAGR of 5.3% during the forecast by 2032.
What is the Market segment?
On the basis of type, the is segmented into Types.
Who are the key players operating in the ?
The major players operating in the are Company.
Select Licence Type
Connect with our sales team
Why Future Market Outlook
100%
Customer
Satisfaction
24x7+
Availability - we are always
there when you need us
200+
Fortune 50 Companies trust
Future Market Outlook
80%
of our reports are exclusive
and first in the industry
100%
more data
and analysis
1000+
reports published
till date
